Development and Validation of an HPLC Method to Determine Chemical and Radiochemical Purity of [ 18 F]Florbetazine Injection
Journal of Labelled Compounds and Radiopharmaceuticals · 2025
DOI: 10.1002/jlcr.4140 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Journal of Labelled Compounds and Radiopharmaceuticals, 2025. Verfasst von Fuhai Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, College of Chemistry and Life Science, Center of Excellence for Environmental Safety and Biological Effects, Beijing Univers…. Hauptthemen laut MEDLINE: Aniline Compounds, Tropanes, Radiopharmaceuticals. Die Arbeit nennt 20 Literaturangaben. Gefördert von: Nuclear Technology R&D Program, Beijing Municipal Science and Technology Commission, Administrative Commission of Zhongguancun Science Park, State Administration for Science, Technology and Industry for National Defense.
Abstract (Originalsprache)
[ 18 F]Florbetazine injection, a radiotracer that could target Aβ plaques and achieve diagnosis of Alzheimer's disease ( AD ), is a novel positron emission tomography (PET) imaging agent currently in the investigational new drug (IND) application stage. The active ingredient of [ 18 F]Florbetazine injection, [ 18 F]Florbetazine, is a diaryl‐azine derivative. Chemical and radiochemical purity is critical quality attributes (CQAs) for [ 18 F]Florbetazine injection, and thus, we have developed and validated a relevant HPLC method. This study describes the specificity, linearity, accuracy, repeatability, and limit of quantification (LOQ) of the HPLC method. The stability of three sample batches was investigated using the established method. The validation results demonstrated the accuracy, precision, and sensitivity of the method, making it suitable for implementation as part of the quality control (QC) process for [ 18 F]Florbetazine injection. The stability of three sample batches revealed a decrease in concentration and radiochemical purity over 10 h. However, all samples maintained a radiochemical purity of over 90% after 10 h. The results provided a foundation for establishing quality standards for [ 18 F]Florbetazine injection. The same methodology employed in this study could be applied and modified for QC protocols of other 18 F‐labeled radiopharmaceuticals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, College of Chemistry and Life Science, Center of Excellence for Environmental Safety and Biological Effects, Beijing University of Technology, Beijing, China.
- High Tech Atom Co., Ltd., Beijing 102413, China.
- Key Laboratory of Radiopharmaceuticals, Ministry of Education, Beijing Normal University, Beijing, China.
ORCID-Profile: Fuhai Wu
Förderung
- Nuclear Technology R&D Program
- Beijing Municipal Science and Technology Commission, Administrative Commission of Zhongguancun Science Park
- State Administration for Science, Technology and Industry for National Defense
Zitieren
APA
Wu, F., Wang, X., Chen, H., Zhou, X., Zhao, H., & Cui, M. (2025). Development and Validation of an HPLC Method to Determine Chemical and Radiochemical Purity of [ 18 F]Florbetazine Injection. Journal of Labelled Compounds and Radiopharmaceuticals. https://doi.org/10.1002/jlcr.4140
Vancouver
Wu F, Wang X, Chen H, Zhou X, Zhao H, Cui M. Development and Validation of an HPLC Method to Determine Chemical and Radiochemical Purity of [ 18 F]Florbetazine Injection. Journal of Labelled Compounds and Radiopharmaceuticals. 2025. doi:10.1002/jlcr.4140
BibTeX
@article{Wu2025,
author = {Wu, Fuhai and Wang, Xiaoming and Chen, Huan and Zhou, Xu and Zhao, Hailong and Cui, Mengchao},
title = {Development and Validation of an HPLC Method to Determine Chemical and Radiochemical Purity of [ 18 F]Florbetazine Injection},
journal = {Journal of Labelled Compounds and Radiopharmaceuticals},
year = {2025},
doi = {10.1002/jlcr.4140}
}
EUVIMED